
Checkpoint Capital L.P. is a Sector-focused Hedge Fund led by Tony Michael Berta, reporting $194.3M in AUM as of Q3 2025 with 97% Healthcare concentration, with only 9 positions, and 41% allocation to RYTM.
Largest long holdings in Checkpoint Capital L.P.'s portfolio (100% of total portfolio)
| Holding | Sector | Position | Weight | Traded | Ownership |
|---|---|---|---|---|---|
Biotechnology Healthcare | $77.1M | 41.06% | -$29.9M Sold | 1.15% 763.7K shares | |
Biotechnology Healthcare | $32.6M | 17.36% | +$4.0M Bought | 0.37% 392.3K shares | |
Biotechnology Healthcare | $28.4M | 15.13% | +$10.9M Bought | 1.24% 430.0K shares | |
Biotechnology Healthcare | $23.0M | 12.24% | +$9.9M Bought | 0.26% 492.3K shares | |
Biotechnology Healthcare | $10.8M | 5.77% | +$10.8M New | 0.28% 260.0K shares | |
Unknown Unknown | $5.3M | 2.84% | -$5.7M Sold | 0.64% 283.2K shares | |
Biotechnology Healthcare | $5.0M | 2.65% | +$5.0M Bought | 0.39% 212.0K shares | |
Biotechnology Healthcare | $3.5M | 1.86% | -$2.6M Sold | 0.09% 61.8K shares | |
Biotechnology Healthcare | $2.1M | 1.10% | +$2.1M Bought | 0.03% 37.6K shares |
Portfolio activity, position movements, and quarter-over-quarter changes in Checkpoint Capital L.P.'s latest filing
| Position | Shares Δ |
|---|---|
New | |
+75.82% | |
+62.26% | |
+14.08% |
| Position | Shares Δ |
|---|---|
Sold | |
-51.72% | |
-42.28% | |
-27.95% |
Portfolio insights and performance metrics for Checkpoint Capital L.P.
We use cookies for analytics. See our Privacy and Cookie Policy.